Single-site chemical modification at C10 of the baccatin III core of paclitaxel and Taxol C reduces P-glycoprotein interactions in bovine brain microvessel endothelial cells

Bioorg Med Chem Lett. 2006 Feb;16(3):495-8. doi: 10.1016/j.bmcl.2005.10.063. Epub 2005 Nov 10.

Abstract

A single-site modification of paclitaxel analogs at the C10 position on the baccatin III core that reduces interaction with P-glycoprotein in bovine brain microvessel endothelial cells is described. Modification and derivatization of the C10 position were carried out using a substrate controlled hydride addition to a key C9 and C10 diketone intermediate. The analogs were tested for tubulin assembly and cytotoxicity, and were shown to retain potency similar to paclitaxel. P-glycoprotein interaction was examined using a rhodamine assay and it was found that simple hydrolysis or epimerization of the C10 acetate of paclitaxel and Taxol C can reduce interaction with the P-glycoprotein transporter that may allow for increased permeation of taxanes into the brain.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Alkaloids / chemistry*
  • Alkaloids / pharmacology
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Brain / cytology*
  • Cattle
  • Drug Interactions
  • Endothelial Cells / metabolism*
  • Female
  • Microcirculation
  • Paclitaxel / chemistry*
  • Paclitaxel / pharmacology
  • Permeability
  • Rhodamines / metabolism
  • Taxoids / chemistry*
  • Taxoids / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Alkaloids
  • Antineoplastic Agents
  • Rhodamines
  • Taxoids
  • baccatin III
  • Paclitaxel